Fibrinolysis: A Primordial System Linked to the Immune Response.

Int J Mol Sci

Molecular Neurotrauma and Haemostasis Laboratory, Australian Centre for Blood Diseases, Central Clinical School Melbourne, Monash University, Melbourne, VIC 3004, Australia.

Published: March 2021

The fibrinolytic system provides an essential means to remove fibrin deposits and blood clots. The actual protease responsible for this is plasmin, formed from its precursor, plasminogen. Fibrin is heralded as it most renowned substrate but for many years plasmin has been known to cleave many other substrates, and to also activate other proteolytic systems. Recent clinical studies have shown that the promotion of plasmin can lead to an immunosuppressed phenotype, in part via its ability to modulate cytokine expression. Almost all immune cells harbor at least one of a dozen plasminogen receptors that allows plasmin formation on the cell surface that in turn modulates immune cell behavior. Similarly, a multitude of pathogens can also express their own plasminogen activators, or contain surface proteins that provide binding sites host plasminogen. Plasmin formed under these circumstances also empowers these pathogens to modulate host immune defense mechanisms. Phylogenetic studies have revealed that the plasminogen activating system predates the appearance of fibrin, indicating that plasmin did not evolve as a fibrinolytic protease but perhaps has its roots as an immune modifying protease. While its fibrin removing capacity became apparent in lower vertebrates these primitive under-appreciated immune modifying functions still remain and are now becoming more recognised.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037105PMC
http://dx.doi.org/10.3390/ijms22073406DOI Listing

Publication Analysis

Top Keywords

plasmin formed
8
immune modifying
8
immune
6
plasmin
6
plasminogen
5
fibrinolysis primordial
4
primordial system
4
system linked
4
linked immune
4
immune response
4

Similar Publications

Fibrin film on clots is increased by haematocrit but reduced by inflammation: implications for platelets and fibrinolysis.

J Thromb Haemost

January 2025

Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.

Background: Blood clot formation, triggered by vascular injury, is crucial for haemostasis and thrombosis. Blood clots are composed mainly of fibrin fibres, platelets and red blood cells (RBCs). Recent studies show that clot surface also develops a fibrin film, which provides protection against wound infection and retains components such as RBCs within the clot.

View Article and Find Full Text PDF

Vascular malformations are common vascular lesions in infants and seriously affect their health and quality of life. Vascular sclerotherapy is an effective treatment for vascular malformations. However, current sclerosants have difficulty achieving both high efficiency and low toxicity, and their dosing forms make it difficult to achieve long-term retention in the affected blood vessels.

View Article and Find Full Text PDF
Article Synopsis
  • ANGPTL3/4/8 proteins regulate lipoprotein lipase (LPL) activity, with ANGPTL8 forming complexes that influence ANGPTL4's function; however, their association with cardiovascular outcomes is under-researched.
  • This study involved measuring various ANGPTL proteins and complexes in two large population studies (LURIC and getABI) focusing on cardiovascular health and outcomes over several years.
  • Findings showed that while ANGPTL3/8 inhibited LPL activity and correlated with increased LDL-C and triglycerides, they did not predict cardiovascular death; however, ANGPTL4/8 and CD-ANGPTL4 were linked to higher diabetes prevalence and increased cardiovascular mortality risk.
View Article and Find Full Text PDF
Article Synopsis
  • * In this condition, retinal pigment epithelial cells lose their anchor to a supportive membrane, become more mobile, and migrate to the retinal surface, which can worsen vision.
  • * Research indicates that annexin A2 plays a key role in this process by aiding the movement of these retinal cells when stimulated by specific inflammatory proteins, and targeting these proteins in mice may help reduce the condition's progression.
View Article and Find Full Text PDF
Article Synopsis
  • Baicalin, a flavonoid from Scutellaria baicalensis, exhibits strong antitumor and apoptosis-inducing properties, making it a potential candidate for new cancer drugs.
  • The study identified Annexin A2 as the target protein for baicalin, which, when combined with S100A10, activates processes linked to cancer progression and apoptosis inhibition.
  • Experiments with HepG2 cells lacking Annexin A2 confirmed that the antitumor effects of baicalin depend on this protein, suggesting that targeting Annexin A2 could lead to effective cancer treatments.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!